National Shipment Approval and Distribution Temperature Verification with Digital Certificates

Pharmaceutical supply chain management company M2Cloud announced on October 6 that it will expand its ‘Digital Biologics Shipment Certificate’ system—which digitally records and manages vaccine distribution history—to cover the vaccine management stage within medical institutions.


Moderna Vaccine Storage and Thawing Management IoT Solution 'Cold Care'. M2Cloud

Moderna Vaccine Storage and Thawing Management IoT Solution 'Cold Care'. M2Cloud

View original image

Previously, the Korea Disease Control and Prevention Agency and the Ministry of Food and Drug Safety announced the ‘National Immunization Vaccine Quality Control and Safety Vaccination Enhancement Plan’ on September 30, which shifts vaccine safety management from stage-by-stage control to full lifecycle management while reinforcing vaccine management systems at medical institutions. The plan includes improvements such as a procedure for pre-verifying whether delivered vaccines have received national shipment approval, expanding the use of automatic temperature recorders, and implementing daytime and nighttime temperature management through remote notifications.


M2Cloud’s Digital Biologics Shipment Certificate enables medical institutions to confirm national lot release approval information and temperature records from the distribution process using a digital certificate instead of paper documents when receiving vaccines. Once medical personnel review the information, they acknowledge receipt with a digital signature, and the confirmation data along with the time of receipt are recorded digitally.


This system was also applied to the national vaccine supply chain management project during the COVID-19 pandemic. M2Cloud explained, “As the contractor for the Korea Disease Control and Prevention Agency’s national COVID-19 vaccine integrated logistics system, we deployed the Digital Biologics Shipment Certificate in the supply chain system, which was used to manage the distribution of COVID-19 vaccines to some 17,000 sites nationwide.”


At the storage stage within medical institutions, IoT devices and ‘mChain’ are utilized. This system allows real-time monitoring of vaccine storage temperatures and alerts staff if preset conditions are breached. It also manages each vaccine’s expiration date and allowable usage time. As of now, the system is in operation at over 1,000 medical institutions.


M2Cloud plans to link the shipment certificates used during distribution with the in-house storage management system to ensure traceability and management records continue after the vaccine has been delivered to a medical institution. Based on IoT security technology, the company has established a system that enables regulatory compliance to be verified with data during biopharmaceutical cold chain management. The platform was developed in line with requirements of the U.S. Food and Drug Administration’s (FDA) regulations on electronic records and signatures (21 CFR Part 11) as well as the Drug Supply Chain Security Act (DSCSA).


Jinsu Moon, CEO of M2Cloud, stated, “The quality of pharmaceuticals should be proven by data,” adding, “We will extend the technologies applied in national vaccine projects to the clinical field to support continuous record-keeping throughout both distribution and storage stages.”



Meanwhile, starting at the end of this month, M2Cloud will provide the vaccine management program ‘ColdCare’ in partnership with Moderna. The solution will be used for vaccines supplied by Moderna, managing thawing processes, storage temperatures, and each vaccine’s expiration period, and will automatically alert responsible staff if preset conditions are breached.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing